(Q46693199)

24 December 2017

title

Improved survival in women with BRCA-associated ovarian carcinoma (English)

1 reference

24 December 2017

5

Steven A Narod

1 reference

24 December 2017

author name string

Ilana Cass

1

1 reference

24 December 2017

Rae Lynn Baldwin

2

1 reference

24 December 2017

Taz Varkey

3

1 reference

24 December 2017

Roxana Moslehi

4

1 reference

24 December 2017

Beth Y Karlan

6

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

24 December 2017

published in

Cancer

1 reference

24 December 2017

volume

97

1 reference

24 December 2017

issue

9

1 reference

24 December 2017

page(s)

2187-2195

1 reference

24 December 2017

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Familial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Gene-Expression Profiles in Hereditary Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Preoperative CA-125 levels in patients with hereditary compared to sporadic epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Association of BRCA1 with Rad51 in mitotic and meiotic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Cell proliferation and apoptosis in BRCA-associated hereditary ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

BRCA1 physically associates with p53 and stimulates its transcriptional activity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

p53 mutations in BRCA1-associated familial breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

p53 mutations and expression in ovarian cancers: correlation with overall survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

A genetic epidemiological study of carcinoma of the fallopian tube

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11310

7 January 2021

Identifiers

DOI

10.1002/CNCR.11310

1 reference

24 December 2017

1 reference

24 December 2017